NVIDIA CORPNVIDIA CORP

Institutional investor · Portfolio as of Q4 2023

SEC EDGAR SourceSEC Filings

Top Holdings5 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction
ARMARM
ADR

ARM Holdings PLC Sponsored ADR

2M$147.3M63.9%$75.140.00%
1 qtr
New
96

RECURSION PHARMACEUTICALS IN

7.7M$76M33.0%$9.860.00%
1 qtr
New
95

SOUNDHOUND AI INC

1.7M$3.7M1.6%$2.120.00%
1 qtr
New
64

CreateAI Holdings Inc.

3.5M$3M1.3%
1 qtr
New
63

NANO X IMAGING LTD

59,632$379,8560.2%$6.370.00%
1 qtr
New
42
$230.4M
AUM
5
Positions
Q4 2023
Filing
Rating · 2.0
Quarterly Portfolio Change
Not enough history yet
Activity profile
$ moved · Q4'23
New100%Increased0%Decreased0%Exited0%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
<1Q100%1-4Q0%1-2Y0%2Y+0%

NVIDIA CORP manages $230.4M across 5 positions as of Q4 2023. Top holdings: ARM (63.9%), RXRX (33.0%), SOUN (1.6%). Fund DNA: Concentrated Value. HoldingsIntel Rating: 2/5.0.

Q4 2023 Summary

Added 5 new positions. Top move: ARM (NEW, conviction 96). Portfolio: $230M across 5 positions.

Top holdings by portfolio weight

Total AUM$230M
ARM63.95%
RXRX32.98%
SOUN1.59%
TSPH1.32%
NNOX0.16%

Portfolio allocation by GICS sector

Sectors2
Technology66.86%
Healthcare33.14%

Behavioral investing profile

Checking access…
Concentrated Value- primarily Technology, Healthcare
Compare DNA across all funds
7-dimension quality assessment
Below Average(2.0 / 5.0)
Track Record84
Conviction45
Concentration100
Checking access…

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

No active accumulation streaks detected for this filer.

Streaks require 2+ consecutive quarters of increased positions in the most recent period.

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used